Follow the people · Insider
John S. Montalbano
John S. Montalbano files insider transactions with the SEC as a director of AbCellera Biologics (ABCL). We hold 2 disclosed purchases and sales filed since 17 December 2020, 1 of them in the last 90 days.
- Files forABCL
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 November 2020 — 18 August 2026Director · AbCellera Biologics (ABCL)19 Form 4 lines · source: SEC Form 4
Everything they disclosed
19 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 10,000 shares of AbCellera BiologicsSEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- was granted 111,701 shares of AbCellera Biologics (a derivative holding)SEC Form 412 June 2026Share option (right to buy) · traded 11 June 2026 · filed 12 June 2026
- ▲ bought on the open market 20,000 shares of AbCellera BiologicsSEC Form 418 May 2026Common Shares · traded 14 May 2026 · filed 18 May 2026
- ▲ bought on the open market 50,000 shares of AbCellera BiologicsSEC Form 426 November 2025Common Shares · traded 26 November 2025 · filed 26 November 2025
- was granted 238,864 shares of AbCellera Biologics (a derivative holding)SEC Form 416 June 2025Share option (right to buy) · traded 12 June 2025 · filed 16 June 2025
- ▲ bought on the open market 25,000 shares of AbCellera BiologicsSEC Form 410 March 2025Common Shares · traded 10 March 2025 · filed 10 March 2025
- ▲ bought on the open market 60,000 shares of AbCellera BiologicsSEC Form 47 March 2025Common Shares · traded 6 March 2025 · filed 7 March 2025
- was granted 163,934 shares of AbCellera Biologics (a derivative holding)SEC Form 424 June 2024Share option (right to buy) · traded 21 June 2024 · filed 24 June 2024
- ▲ bought on the open market 20,000 shares of AbCellera BiologicsSEC Form 48 November 2023Common Shares · traded 6 November 2023 · filed 8 November 2023
- ▲ bought on the open market 10,000 shares of AbCellera BiologicsSEC Form 48 November 2023Common Shares · traded 8 November 2023 · filed 8 November 2023
- was granted 47,231 shares of AbCellera Biologics (a derivative holding)SEC Form 45 December 2022Share option (right to buy) · traded 1 December 2022 · filed 5 December 2022
- ▲ bought on the open market 10,000 shares of AbCellera BiologicsSEC Form 44 March 2022Common Shares · traded 4 March 2022 · filed 4 March 2022
- ▲ bought on the open market 20,000 shares of AbCellera BiologicsSEC Form 43 March 2022Common Shares · traded 1 March 2022 · filed 3 March 2022
- was granted 34,282 shares of AbCellera Biologics (a derivative holding)SEC Form 410 December 2021Share option (right to buy) · traded 27 August 2021 · filed 10 December 2021
- was granted 45,532 shares of AbCellera Biologics (a derivative holding)SEC Form 410 December 2021Share option (right to buy) · traded 7 December 2021 · filed 10 December 2021
- ▲ bought on the open market 6,000 shares of AbCellera BiologicsSEC Form 417 August 2021Common Shares · traded 16 August 2021 · filed 17 August 2021
- was granted 500,000 shares of ABCL (a derivative holding)SEC Form 417 December 2020Stock Option (right to buy) · traded 18 November 2020 · filed 17 December 2020
- ▲ bought on the open market 20,000 shares of ABCLSEC Form 417 December 2020Common Shares · traded 15 December 2020 · filed 17 December 2020
- ▲ bought on the open market 5,000 shares of ABCLSEC Form 417 December 2020Common Shares · traded 15 December 2020 · filed 17 December 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.